Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2013 October;79(10) > Minerva Anestesiologica 2013 October;79(10):1173-9

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

EXPERT OPINIONS   Free accessfree

Minerva Anestesiologica 2013 October;79(10):1173-9

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

Management of refractory hypoxemia in ARDS

Kacmarek R. M. 1, 2, Villar J. 3, 4, 5

1 Department of Respiratory Care, Massachusetts General Hospital, Boston, MA, USA; 2 Department of Anesthesia, Harvard University, Boston, MA, USA; 3 CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain; 4 Research Unit, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain; 5 Keenan Research Center at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, ON, Canada


PDF


Severe hypoxemia is the hallmark of ARDS. However, unmanageable refractory hypoxemia fortunately is a rare occurrence in patients with ARDS and an infrequent cause of death in ARDS. However, in some patients, in spite of the application of lung protective ventilation with moderate to high levels of end-expiratory pressure (PEEP), refractory hypoxemia remains unresolved. When refractory hypoxemia persists, we first recommend the use of lung recruitment maneuvers and a decremental PEEP trial, if this does not resolve the refractory hypoxemia prone positioning should be attempted. The use of aerosolized pulmonary vasodilators can be used to buy time when these approaches fail as the patient is transitioned to extracorporeal membrane oxygenation. We also find that there is now sufficient evidence to recommend against the use of high frequency oscillation in the management of refractory hypoxemia.

top of page